Instalab
logoInstalab

Babesia Microti Antibody IgG Screen

Blood Test
Look for evidence of exposure to a tick-borne cause of fever and anemia.
4.8 (4,913 reviews)
Tested by Quest or Access Medical
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Babesia Microti Antibody IgG Screen test?

This test is most useful if any of these apply to you.

Unwell After Time in Tick Country
Fever, sweats, or anemia after possible tick exposure can warrant a babesiosis workup, including PCR or a blood smear.
Investigating an Earlier Unexplained Fever
Antibody testing may support evidence of an earlier infection after the initial illness has passed.
Living Without a Spleen and Feeling Unwell
Fever after possible exposure needs urgent assessment; an antibody screen alone can miss infection.
Still Feverish During Lyme Treatment
Persistent fever or unexplained anemia can suggest a second tick-borne infection that Lyme treatment doesn't cover.

About Babesia Microti Antibody IgG Screen

An unexplained fever after possible tick exposure can raise suspicion for babesiosis, especially when it comes with anemia or low platelets. Babesia microti IgG screening looks for your immune response to the parasite. A positive result supports past or current infection, but it cannot establish that the parasite is causing your symptoms now.

A Parasite That Lives in Red Blood Cells

Babesia microti is a single-celled parasite transmitted mainly by infected blacklegged ticks in the United States. Mice and other small mammals help maintain its cycle in nature. Inside your body, it multiplies in red blood cells and contributes to their destruction. Infection can also spread through contaminated blood transfusions and, rarely, from mother to baby.

What This Screen Reports

IgG is a class of antibody that can remain after an infection has resolved. This established antibody test uses serum from a blood draw. Serum is the liquid left after blood clots. An indirect immunofluorescence assay, or IFA, detects whether your IgG binds to material from B. microti.

The screen reports detected or not detected. A positive screen can lead to a separate antibody titer. A titer describes how far the sample can be diluted while antibody binding remains detectable. The screening result itself has no numerical antibody level, and neither result counts parasites in your blood.

What Babesiosis Looks Like

Some infections cause no symptoms. Others cause fever, chills, sweats, fatigue, headache, or body aches. Red blood cell destruction can cause anemia, jaundice, and dark urine. Low platelets and raised liver enzymes are common laboratory findings during symptomatic illness, though these findings also occur in other diseases.

Older adults, people without a functioning spleen, and people with weakened immune systems have a greater risk of severe illness. Persistent or relapsing infection is a particular concern with B-cell cancers and treatments such as rituximab. B cells help produce antibodies, so disrupting them can impair the response to the parasite. Severe disease can also occur outside these groups.

Complications After the Initial Illness

Babesiosis can sometimes trigger autoimmune hemolytic anemia. This happens when the immune system attacks your own red blood cells. In one case series, six people without spleens developed the warm-antibody form two to four weeks after their babesiosis diagnosis, despite treatment and clearance of parasites from blood smears. A cold-antibody form has also been reported. These antibodies against red blood cells are different from the antibodies against B. microti detected by this screen.

Lyme Disease and Other Tick Infections

The same blacklegged ticks can transmit Lyme disease, babesiosis, and anaplasmosis. Having one infection therefore raises the possibility of another, but antibodies to several organisms do not establish that several infections are active. Persistent fever or unexplained blood count abnormalities during a Lyme illness make coinfection more relevant than fatigue alone.

Exposure Can Go Unnoticed

Antibody surveys find evidence of exposure in people who never recognized an illness. An older study in eastern Switzerland found B. microti IgG in 1.5% of the residents tested. That figure describes one place and study population; it isn't an estimate of your risk after a tick bite.

A study in Sweden and the Åland Islands followed 53 people bitten by Babesia-positive ticks, along with a comparison group. No participant developed newly detectable B. microti IgG during follow-up, and no one in the exposed group reported symptoms suggestive of babesiosis. The ticks carried several Babesia species while the antibody test targeted B. microti, which limits conclusions about infection by other species.

Blood Donation and Transfusion

An infected blood donor can feel well and still transmit the parasite. A research program screened 89,153 donations using a different antibody assay together with DNA testing and identified potentially infectious donations. That study supports blood donation screening; it does not establish the performance of this IgG screen alone. US blood centers use dedicated tests for parasite genetic material in regions covered by FDA screening recommendations.

How the Antibody Response Changes

Parasites can be detectable before antibodies appear. The timing varies, so there is no dependable day after a bite when a negative IgG screen rules out infection. Human blood donor studies have documented samples that were positive for parasite DNA while antibody tests were still negative.

Antibodies can persist for a year or more after apparent clearance of infection. In an older follow-up study of 16 people, serum antibody titers rose during the first weeks of illness and then fell gradually over five to six months. Those were titer measurements, not numerical results from a qualitative screen. A falling titer or a persistently positive screen cannot, by itself, establish whether treatment succeeded.

How Accurate the Test Is

An older four-laboratory study of serum IFA testing detected most established babesiosis cases, with sensitivity ranging from 88% to 96%. Specificity ranged from 90% to 100%. These estimates came from a small validation study and do not describe the reliability of testing before an antibody response develops.

Research assays are exploring earlier detection. In a 2025 study, an experimental bead-based IgG assay detected antibodies in six of 13 human samples that were PCR-positive but negative by IFA. That result belongs to the experimental assay. It does not mean this screen has the same ability to detect early infection.

When Results Can Be Misleading

  • Early infection: IgG may still be undetectable when parasites are already present in your blood.
  • Past infection: Antibodies can remain detectable long after symptoms resolve, so a positive result does not establish current illness.
  • Impaired antibody production: Rituximab and some B-cell disorders can weaken or delay the antibody response. Responses vary, and a negative screen can miss infection.
  • Other Babesia species: This screen targets B. microti. It does not reliably exclude infections caused by B. duncani, B. divergens, or B. venatorum.
  • Cross-reactions and laboratory interpretation: Malaria antibodies can sometimes react in Babesia IFA testing. The fluorescent pattern requires interpretation, and laboratories can disagree.
  • Low likelihood of infection before testing: An unexpected positive result is more likely to be misleading when there is no compatible illness or plausible exposure.
  • Different report formats: A detected/not-detected screen, a dilution titer, and an index from another antibody method are different results. Their numbers and labels cannot be treated as interchangeable.

What Serial Results Can Show

A change from not detected to detected can support an antibody response developing over time. Repeated positive screens provide no information about whether the amount of antibody has risen or fallen. Paired titers can provide additional evidence about a recent infection, but antibody results alone are a poor measure of recovery.

What Moves This Biomarker

Evidence-backed interventions that affect your Babesia Microti Antibody IgG Screen level

↑ Increase
B. microti infection acquired through a tick bite
Infection can stimulate IgG production and change the screen from not detected to detected, even if you never develop symptoms. The positive result can remain after the infection resolves.
LifestyleModerate Evidence

Frequently Asked Questions

Panels containing Babesia Microti Antibody IgG Screen

Babesia Microti Antibody IgG Screen is included in these pre-built panels.

References

24 studies
  1. Centers for Disease Control and PreventionCDC2024
  2. Centers for Disease Control and PreventionCDC DPDx2024
  3. Centers for Disease Control and PreventionCDC2024

Babesia Microti Antibody IgG Screen Testing Option

Babesia Microti Antibodies

$509

See whether your body has met the blood parasite behind babesiosis, and whether that encounter looks recent or long past.

Includes 4 biomarkers:
Babesia Microti Antibody IgG ScreenBabesia Microti IgM TiterBabesia Microti IgG TiterBabesia Microti Antibody IgM Screen
FSA/HSA eligible
No Rx needed
HIPAA compliant